OM-85 Broncho-Vaxom(®), a Bacterial Lysate, Reduces SARS-CoV-2 Binding Proteins on Human Bronchial Epithelial Cells

In clinical studies, OM-85 Broncho-Vaxom(®), a bacterial lysate, reduced viral respiratory tract infection. Infection of epithelial cells by SARS-CoV-2 depends on the interaction of its spike-protein (S-protein) with host cell membrane proteins. In this study, we investigated the effect of OM-85 on...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Lei, Zhou, Liang, Tamm, Michael, Roth, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615539/
https://www.ncbi.nlm.nih.gov/pubmed/34829773
http://dx.doi.org/10.3390/biomedicines9111544

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615539/
https://www.ncbi.nlm.nih.gov/pubmed/34829773
http://dx.doi.org/10.3390/biomedicines9111544

Ejemplares similares